FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000384927> ?p ?o ?g. }

• W2000384927 endingPage "409" @default.
• W2000384927 startingPage "403" @default.
• W2000384927 abstract "Abstract: Objectives: Thalidomide has demonstrated a remarkable efficacy in the treatment of multiple myeloma but its use may cause several toxicities. We have investigated the common and rare side‐effects, especially analysing peripheral neuropathy, in order to optimise the thalidomide dose for minimizing this harmful side‐effect. Methods: Fifty‐nine patients were treated with thalidomide alone or combined with oral melphalan. The median age was 69 yr. The initial dose of thalidomide was 100 mg/day increasing weekly by 100 mg increments until a maximum dose of 400 mg was attained. Melphalan was administered at a dose of 0.20 mg/kg/d for 4 d every 28 d. Results and conclusions: Nearly one‐fourth of patients discontinued thalidomide because of toxicity. Constipation (71%), somnolence (36%) and fatigue (20%) were the most common side‐effects and they were not dose dependent. Peripheral neuropathy occurred in 39% of patients and a thalidomide median daily dose of more than 150 mg was significantly associated with higher frequency and actuarial risk of peripheral neuropathy without improving the response rate. Deep venous thrombosis was observed in 7% of patients and other side‐effects were rare. In patients with advanced multiple myeloma we found that a thalidomide daily dose of 150 mg minimizes peripheral neuropathy without jeopardizing response and survival." @default.
• W2000384927 created "2016-06-24" @default.
• W2000384927 creator A5017681466 @default.
• W2000384927 creator A5022330993 @default.
• W2000384927 creator A5044244099 @default.
• W2000384927 creator A5046242522 @default.
• W2000384927 creator A5046312032 @default.
• W2000384927 creator A5050982431 @default.
• W2000384927 creator A5062179506 @default.
• W2000384927 creator A5062380183 @default.
• W2000384927 creator A5063734987 @default.
• W2000384927 creator A5071273767 @default.
• W2000384927 creator A5083644983 @default.
• W2000384927 creator A5086792856 @default.
• W2000384927 creator A5086831338 @default.
• W2000384927 date "2004-05-04" @default.
• W2000384927 modified "2023-10-15" @default.
• W2000384927 title "Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy" @default.
• W2000384927 cites W1978377409 @default.
• W2000384927 cites W1982377576 @default.
• W2000384927 cites W2018734375 @default.
• W2000384927 cites W2039166615 @default.
• W2000384927 cites W2043046274 @default.
• W2000384927 cites W2067456806 @default.
• W2000384927 cites W2078945448 @default.
• W2000384927 cites W2088834215 @default.
• W2000384927 cites W2120457540 @default.
• W2000384927 cites W2123620596 @default.
• W2000384927 cites W2132242107 @default.
• W2000384927 cites W2136113007 @default.
• W2000384927 cites W2136226957 @default.
• W2000384927 cites W2146126581 @default.
• W2000384927 cites W2167805334 @default.
• W2000384927 cites W2316160054 @default.
• W2000384927 cites W4293241248 @default.
• W2000384927 doi "https://doi.org/10.1111/j.1600-0609.2004.00238.x" @default.
• W2000384927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15128418" @default.
• W2000384927 hasPublicationYear "2004" @default.
• W2000384927 type Work @default.
• W2000384927 sameAs 2000384927 @default.
• W2000384927 citedByCount "45" @default.
• W2000384927 countsByYear W20003849272012 @default.
• W2000384927 countsByYear W20003849272013 @default.
• W2000384927 countsByYear W20003849272014 @default.
• W2000384927 countsByYear W20003849272016 @default.
• W2000384927 countsByYear W20003849272017 @default.
• W2000384927 countsByYear W20003849272018 @default.
• W2000384927 countsByYear W20003849272019 @default.
• W2000384927 countsByYear W20003849272021 @default.
• W2000384927 crossrefType "journal-article" @default.
• W2000384927 hasAuthorship W2000384927A5017681466 @default.
• W2000384927 hasAuthorship W2000384927A5022330993 @default.
• W2000384927 hasAuthorship W2000384927A5044244099 @default.
• W2000384927 hasAuthorship W2000384927A5046242522 @default.
• W2000384927 hasAuthorship W2000384927A5046312032 @default.
• W2000384927 hasAuthorship W2000384927A5050982431 @default.
• W2000384927 hasAuthorship W2000384927A5062179506 @default.
• W2000384927 hasAuthorship W2000384927A5062380183 @default.
• W2000384927 hasAuthorship W2000384927A5063734987 @default.
• W2000384927 hasAuthorship W2000384927A5071273767 @default.
• W2000384927 hasAuthorship W2000384927A5083644983 @default.
• W2000384927 hasAuthorship W2000384927A5086792856 @default.
• W2000384927 hasAuthorship W2000384927A5086831338 @default.
• W2000384927 hasConcept C126322002 @default.
• W2000384927 hasConcept C134018914 @default.
• W2000384927 hasConcept C141071460 @default.
• W2000384927 hasConcept C197934379 @default.
• W2000384927 hasConcept C199360897 @default.
• W2000384927 hasConcept C2776364478 @default.
• W2000384927 hasConcept C2778684742 @default.
• W2000384927 hasConcept C2779034229 @default.
• W2000384927 hasConcept C2779609412 @default.
• W2000384927 hasConcept C2779901536 @default.
• W2000384927 hasConcept C2781112942 @default.
• W2000384927 hasConcept C29730261 @default.
• W2000384927 hasConcept C3454156 @default.
• W2000384927 hasConcept C41008148 @default.
• W2000384927 hasConcept C555293320 @default.
• W2000384927 hasConcept C71924100 @default.
• W2000384927 hasConcept C90924648 @default.
• W2000384927 hasConceptScore W2000384927C126322002 @default.
• W2000384927 hasConceptScore W2000384927C134018914 @default.
• W2000384927 hasConceptScore W2000384927C141071460 @default.
• W2000384927 hasConceptScore W2000384927C197934379 @default.
• W2000384927 hasConceptScore W2000384927C199360897 @default.
• W2000384927 hasConceptScore W2000384927C2776364478 @default.
• W2000384927 hasConceptScore W2000384927C2778684742 @default.
• W2000384927 hasConceptScore W2000384927C2779034229 @default.
• W2000384927 hasConceptScore W2000384927C2779609412 @default.
• W2000384927 hasConceptScore W2000384927C2779901536 @default.
• W2000384927 hasConceptScore W2000384927C2781112942 @default.
• W2000384927 hasConceptScore W2000384927C29730261 @default.
• W2000384927 hasConceptScore W2000384927C3454156 @default.
• W2000384927 hasConceptScore W2000384927C41008148 @default.
• W2000384927 hasConceptScore W2000384927C555293320 @default.
• W2000384927 hasConceptScore W2000384927C71924100 @default.
• W2000384927 hasConceptScore W2000384927C90924648 @default.
• W2000384927 hasIssue "6" @default.

• next